-
Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
Biohaven Pharmaceuticals
- Thread starter anonymous
- Start date
-
- Tags
- None
Yet, here you are on this thread responding. You’re a douche.
Look at you, Sales Specialist! You're gonna rock out!
Totally agree. Good luck. Too many reps .. Niched drug. Who cares if it’s a disintegratable? Big deal..me too .. same as...you have your work cut out for you. Now you can really earn your big old salary and actually detail something. ( laughable)
Why do you care about anything they do? You come across like a bitter little bitch.
I might buy what you are saying except you are ignoring the fact that there are multiple other drugs in late-stage with the company. Could change everything.
uhhh, ya like I said the date was never a secret.. idiot. In fact it came out only 1 week prior to the Vegas launch meeting.
Yes, because no new drugs have EVER been brought to market and faced prior auth and formulary before...you are an idiot.
that person better get a job with a generics company. Virtually every new drug launch is hit with PAs.
how many whiny brats from Supernus did we hire?
Is Biohaven still hiring for the migraine drug or have they filled all the positions?
I don't know about Biohaven, but I've definitely filled, in all of the positions.
You poor things.. can’t access anyone in your territory. Heard from MY customer they don’t have time to see you. #sosad#toldya
PA’s are not a problem if you are credible and people like you. Folks that start with excuses are seldom credible or liked. Go figure.